Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand

AIDS

Volumn 18, Issue 2, 2004, Pages 295-301

  Van Griensven, Frits ^a,e   Keawkungwal, Jaranit ^b   Tappero, Jordan W ^a,e   Sangkum, Udomsak ^c   Pitisuttithum, Punnee ^b   Vanichseni, Suphak ^d   Suntharasamai, Pravan ^b   Orelind, Karin ^f   Gee, Carolyn ^f   Choopanya, Kachit ^d  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Bangkok Metropolitan Administration   (Thailand)

^d Bangkok Vaccine Evaluation Group   (Thailand)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f VaxGen Inc   (United States)

Author keywords

Asia; HIV 1; Injection drug use; Risk behavior; Thailand; Vaccines

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; METHADONE; METHAMPHETAMINE; MIDAZOLAM;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABUSE; DRUG DEPENDENCE; DRUG DETOXIFICATION; DRUG EFFICACY; EVALUATION; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THAILAND;

ADULT; AGED; AIDS VACCINES; ATTITUDE TO HEALTH; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEEDLE SHARING; PATIENT EDUCATION; RISK-TAKING; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SUBSTANCE ABUSE, INTRAVENOUS; THAILAND;

EID: 10744228834     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200401230-00020     Document Type: Article

References (26)

1. Lurie P, Bishaw M, Chesney M, Cooke M, Fernandes M, Hearst N, et al. Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries. JAMA 1994, 271:295-301.
2. Chesney MA, Lurie P, Coates TJ. Strategies for addressing social and behavioral challenges of prophylactic HIV vaccine trials. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:30-35.
3. Chesney MA, Chambers D, Kahn JO. Risk behavior for HIV infection in participants in preventive HIV vaccine trials. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16:206-271.
4. MacQueen KM, Buchbinder S, Douglas JM, Judson FN, McKirnan DJ, Bartholow B. The decision to enroll in HIV vaccine efficacy trials: concerns elicited from gay men at increased risk for HIV infection. AIDS Res Hum Retroviruses 1994, 10(suppl 2):S261-S264.
5. Meyers K, Metzger DS, Navaline H, Woody GE, McLellan AT. HIV vaccine trials: Will intravenous drug users enroll? Am J Public Health 1994, 84:761-766.
6. Celentano DD, Beyrer C, Natpratan C, Eiumtrakul S, Sussman L, Renzullo PO, et al. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. AIDS 1995, 9:1079-1083.
7. Bartholow BN, MacQueen KM, Douglas JM, Buchbinder S, McKirman DJ, Judson FN. Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16:108-115.
8. Des Jarlais DC, Vanichseni S, Marmor M, Buavirat A, Titus S, Raktham S, et al. Why am I not infected with HIV? Implications for long-term HIV risk reduction and HIV vaccine trials. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16:393-399.
9. Stimson GV, Des Jarlais DC, Ball A. Drug Injecting and HIV Infection: Global Dimensions and Local Responses. London: UCL Press; 1998.
10. Lai S, Liu W, Chen J, Yang J, Li ZJ, Li RJ, et al. Changes in HIV-1 incidence in heroin users in Guangxi Province, China. J Acquir Immune Defic Syndr 2001, 26:365-370.
11. Kitayaporn D, Uneklabh C, Weniger B, Lohsomboon P, Kaewkungwal J, Morgan WM, et al. HIV-1 incidence estimated retrospectively among drug users in Bangkok, Thailand. AIDS 1994, 8:1443-1450.
12. Esparza, J, Osmanov S, Kallings LO, Wigzell H. Planning for HIV vaccine trials: the World Health Organization perspective. AIDS 1991, 5:S159-S163.
13. MacQueen KM, Vanichseni S, Kitayaporn D, Lin LS, Buavirat A, Naiwatanakul T, et al. Willingness of injecting drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand. J Acquir Immune Defic Syndr 1999, 21:243-251.
14. Francis DP, Gregory T, McElrath MJ, Belshe RB, Gorse GJ, Migasena S, et al. Advancing AIDSVAX™ to phase 3. Safety, immunogenicity and plans for phase 3. AIDS Res Hum Retroviruses 1998, 14(suppl 3):S325-S331.
15. Vanichseni S, Kitayaporn D, Mastro TD, Mock PA, Raktham S, Des Jarlais DC, et al. Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS 2001, 15:397-405.
16. Vanichseni S, Tappero JW, Pitisuttithum P, Kitayaporn D, Mastro TD, Vimutisunthorn E, et al. Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX®B/ E HIV vaccine trial, Bangkok, Thailand. AIDS 2004 18:000-000.
17. Kamb, ML, Fishbein M, Douglas JM, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases. A randomized controlled trial. JAMA 1998, 280:1161-1167.
18. Diggle PJ, Liang K, Zeger SL. Analysis of longitudinal data. Oxford: Oxford University Press; 1994.
19. Bartholow B, Buchbinder S, McKirnan D, Goli V, Celum C, VaxGen Study Team. HIV risk behavior change in a phase-III HIV vaccine efficacy trial. AIDS Vaccine Conference. Philadelphia, September 2001 [abstract 324].
20. Shore RE, Marmor M, Titus S, Des Jarlais DC. Methadone maintenance and other factors associated with intraindividual temporal trends in injection drug use. J Subst Abuse Treat 1996, 13:241-248.
21. Ball AL, Rana S, Dehne K. HIV prevention among injecting drug users: responses in developing and transitional countries. Public Health Rep 1998, 113(suppl 1):170-181.
22. Choopanya K, Des Jarlais DC, Vanichseni S, Kitayporn D, Mock PA, Raktham S, et al. Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr 2002, 29:86-94.
23. Buavirat A, Page-Shafer K, van Griensven GJP, Mandel JS, Evans J, Chuaratanaphong J et al. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. Br Med J 2003, 326:308-313.
24. Buavirat A, Sacks R, Chiamwongpat S. HIV risk behaviors during incarceration among intravenous drug users in Bangkok, Thailand: a qualitative approach. AIDS Public Policy 2003, in press.
25. Poshyachinda V, Danthamrongkul V, and Perngparn U. World Drug Report Country Profile: Thailand. (Prepared for UNDCP.) Bangkok: Chulalongkorn University, Institute of Health Research; 1998.
26. Konigs F. Validating population surveys for the measurement of HIV/STD prevention indicators. AIDS 1995, 9:867-873.